CGEM
Cullinan Oncology LLC
15.50$
+6.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.7% | -1.3% | +1.3% | -1.3% | +1.3% | -1.3% | +1.3% | +2.6% | +0.0% | +0.0% | +0.0% | – | |
| – | -2.9% | +9.4% | +28.0% | -10.5% | +2.2% | -2.7% | +5.5% | -4.2% | -22.8% | +4.2% | +10.9% | – | |
| – | – | -278.4% | – | – | +161.7% | -137.2% | – | +32.4% | +10.8% | -153.7% | – | – | |
| – | – | – | – | – | – | – | – | – | -100.0% | -100.0% | – | – | |
| – | – | -74.8% | -1,528.8% | – | -19.7% | +130.5% | +45.1% | +26.2% | -66.8% | +44.8% | +25.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +121.4% | +337.5% | +24,065.5% | -99.5% | +19.4% | -100.0% | – | -100.0% | – | -46.9% | +189.5% | – | |
| – | – | -172.1% | – | -131.7% | – | – | – | – | -149.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.